Pfizer was founded in 1849, in New York, by cousins and German immigrants Charles Pfizer and Charles Erhart, Pfizer was also a pioneer in the production of antibiotics.
As we can see in the company's history, today it has in its portfolio around 100 products in different therapeutic classes for the treatment of various diseases.
Speaking of Global School, the company has 46 industrial units, distributed in 150 countries, with the collaboration of 81.9 thousand employees.
In addition, according wikipedia information, today the company has significant investments and state-of-the-art technology for the discovery and study of new drugs, Pfizer is recognized for its innovation. Currently, the company maintains six research centers for new molecules in the United States and one in England.
Pfizer is a pharmaceutical giant
Currently, thousands of scientists and researchers are involved in the development of new therapies for cardiovascular diseases, central nervous system diseases, men's and women's health, and the treatment of complex diseases such as cancer and AIDS.
In addition to developing and marketing products for human health, the company has a division dedicated to animal health.
Pfizer's activities in Brazil
In Brazil, Pfizer is a leader in several therapeutic segments and exports its products to 60 countries on all continents. It arrived in Brazil in 1952. Currently, the company has 1900 employees, distributed in the Headquarters, in São Paulo, a Manufacturing Unit in Itapevi and offices in several Brazilian capitals.
Pfizer also encompasses social actions, because it understands that this is a key sector in social development.
You know that in Brazil, the company invests in social projects and programs to encourage volunteer work, aimed at health education and reintegration into the community .
Pfizer announces coronavirus vaccine
Pfizer has just announced important advances in the battle against the global COVID-19 pandemic. The company's efforts are focused both on treating the disease and on the possibility of preventing the new coronavirus (Sars-Cov-2), based on a vaccine candidate whose clinical program should start in the coming weeks.
The company is committed to making the impossible possible, so we have hope, because after all, we are talking about a giant, right? We don't have to be desperate, but that's not all. The company also said:
We are collaborating with healthcare industry partners and academic institutions to develop potential new approaches to prevent and treat COVID-19.
They warned: "Our researchers and scientists are also exploring new potential uses of existing drugs in the company's portfolio to help infected patients", The statement was the global CEO of Pfizer, Albert Bourla.
Anyway, did you like it? So share, because it's important for our work!
Source: Pharma portal
